Published in Anal Quant Cytol Histol on April 01, 1992
Double staining cytologic samples with quantitative Feulgen-thionin and anti-Ki-67 immunocytochemistry as a method of distinguishing cells with abnormal DNA content from normal cycling cells. Anal Quant Cytopathol Histpathol (2012) 0.80
Serum microRNA-205 as a novel biomarker for cervical cancer patients. Cancer Cell Int (2014) 0.79
Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology (2005) 3.40
p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol (2000) 3.20
Her-2-neu expression and progression toward androgen independence in human prostate cancer. J Natl Cancer Inst (2000) 2.87
Age at first sex: understanding recent trends in African demographic surveys. Sex Transm Infect (2004) 2.74
Estimating the number of people at risk for and living with HIV in China in 2005: methods and results. Sex Transm Infect (2006) 2.15
HIV surveillance among female sex workers. AIDS (2001) 1.83
To stem HIV in Africa, prevent transmission to young women. AIDS (2001) 1.73
Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 1.67
The cost of unsafe injections. Bull World Health Organ (1999) 1.60
Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases. Hum Pathol (1996) 1.58
Villous adenoma of the urinary tract: a report of 23 cases, including 8 with coexistent adenocarcinoma. Am J Surg Pathol (1999) 1.58
Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis. J Pediatr (1996) 1.56
Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. Oral Oncol (1998) 1.52
Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation. J Pathol (2007) 1.50
Lymphoepithelioma-like carcinoma of the urinary bladder: a clinicopathologic study of 13 cases. Virchows Arch (2001) 1.45
OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol (2007) 1.44
Focal therapy in prostate cancer-report from a consensus panel. J Endourol (2010) 1.43
Enhanced expression of transforming growth factor beta1 in rat thyroid hyperplasia is thyrotropin induced and time dependent. Eur J Endocrinol (1996) 1.41
Mucinous adenocarcinoma with superficial stromal invasion and villous adenoma of urachal remnants: a case report. J Clin Pathol (2003) 1.40
Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Lab Invest (1997) 1.32
A UK-based investigation of inter- and intra-observer reproducibility of Gleason grading of prostatic biopsies. Histopathology (2006) 1.27
Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur Urol (2000) 1.22
HIV surveillance in hard-to-reach populations. AIDS (2001) 1.22
Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients. Prostate (2000) 1.21
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib. Br J Cancer (2012) 1.21
Improved diagnostic decision-making in pathology: do inference networks hold the key? J Pathol (1995) 1.20
Karyometry in the early detection and chemoprevention of intraepithelial lesions. Eur J Cancer (2005) 1.20
Pseudoneoplastic lesions of the testis and paratesticular structures. Virchows Arch (2007) 1.19
Hepatoid adenocarcinoma of the urinary bladder. Virchows Arch (2003) 1.19
Familial aggregation of renal calcium stone disease. J Urol (1988) 1.15
Automated location of dysplastic fields in colorectal histology using image texture analysis. J Pathol (1997) 1.10
Unilateral microfibrillar abnormalities in a case of asymmetric Marfan syndrome. Am J Hum Genet (1990) 1.08
Renal autotransplantation for complete ureteral avulsion following lumbar disk surgery. J Urol (2001) 1.08
Combined yolk sac tumor and adenocarcinoma in a gastric stump: molecular evidence of clonality. Cancer (1999) 1.07
Cellular and molecular pathology of prostate cancer precursors. Scand J Urol Nephrol Suppl (2000) 1.06
Sarcomatoid carcinoma of the anorectal junction with neuroendocrine and rhabdomyoblastic features. Am J Surg Pathol (1995) 1.06
Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles. Radiother Oncol (1998) 1.05
Gastric dysplasia: a ten-year follow-up study. Pathol Res Pract (1994) 1.05
Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1). Eur Urol (2004) 1.04
Nuclear retention of COL1A1 messenger RNA identifies null alleles causing mild osteogenesis imperfecta. J Clin Invest (1996) 1.04
The S100 proteins for screening and prognostic grading of bladder cancer. Histol Histopathol (2007) 1.03
The value of morphometry in prediction of survival in oligodendrogliomas. Clin Neuropathol (1987) 1.02
Prostate tissue and serum markers. Adv Clin Path (2000) 1.01
Activity of levofloxacin and ciprofloxacin against urinary pathogens. J Antimicrob Chemother (2001) 1.00
Chromatin texture signatures in nuclei from prostate lesions. Anal Quant Cytol Histol (1998) 0.99
Osteogenesis imperfecta: clinical, biochemical and molecular findings. Clin Genet (2006) 0.99
Computerized scene segmentation for the discrimination of architectural features in ductal proliferative lesions of the breast. J Pathol (1997) 0.99
Laryngeal leiomyosarcoma. J Laryngol Otol (2000) 0.99
Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up. Int J Immunopathol Pharmacol (2008) 0.99
Precursors of prostatic cancer: progression, regression and chemoprevention. Eur Urol (1996) 0.98
Unusual clinical presentation of a rare case of phyllodes tumor of the breast in an adolescent girl. J Pediatr Surg (2001) 0.97
P53 protein expression in odontogenic cysts. J Endod (2001) 0.96
Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer. J Clin Pathol (2002) 0.95
Treatment of benign prostatic hyperplasia with 5-alpha-reductase inhibitor: morphological changes in patients who fail to respond. J Clin Pathol (1996) 0.94
Nuclear chromatin texture in prostatic lesions. II. PIN and malignancy associated changes. Anal Quant Cytol Histol (1998) 0.94
Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens. J Urol (2005) 0.94
Evaluation of urinary level of NMP22 as a diagnostic marker for stage pTa-pT1 bladder cancer: comparison with urinary cytology and BTA test. Eur Urol (1999) 0.93
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer. Int J Immunopathol Pharmacol (2009) 0.93
Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder. J Clin Pathol (2006) 0.93
Studies on brain density in hemodialysis and peritoneal dialysis. Nephron (1982) 0.92
Computerized diagnostic decision support system for the classification of preinvasive cervical squamous lesions. Hum Pathol (2003) 0.92
Evaluating radical prostatectomy specimens: therapeutic and prognostic importance. Virchows Arch (1997) 0.91
Human cells unable to express decoron produced disorganized extracellular matrix lacking "shape modules" (interfibrillar proteoglycan bridges). Exp Cell Res (1998) 0.91
Bacillus cereus as agent of peritonitis during peritoneal dialysis. Nephron (1984) 0.91
MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas. Neuroradiology (1994) 0.91
Automated reasoning system in histopathologic diagnosis and prognosis of prostate cancer and its precursors. Eur Urol (1996) 0.91
Prognostic role of global DNA-methylation and histone acetylation in pT1a clear cell renal carcinoma in partial nephrectomy specimens. J Cell Mol Med (2008) 0.91
Clinical applications of Bayesian belief networks in pathology. Pathologica (1995) 0.91
The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers. Br J Urol (1991) 0.91
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. Virchows Arch (2000) 0.91
A study of Gleason score interpretation in different groups of UK pathologists; techniques for improving reproducibility. Histopathology (2006) 0.91
Tissue architecture analysis in prostate cancer and its precursors: An innovative approach to computerized histometry. Eur Urol (1999) 0.90
Vascular endothelial growth factor and microvessel density around healthy and failing dental implants. Int J Oral Maxillofac Implants (2001) 0.90
Automated histometry in quantitative prostate pathology. Anal Quant Cytol Histol (1998) 0.89
Mitogen-activated protein kinases and apoptosis in PIN. Virchows Arch (1998) 0.89
Prostatic intra-epithelial neoplasia: expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei. Virchows Arch A Pathol Anat Histopathol (1993) 0.89
Possible role of overglycosylation in the type I collagen triple helical domain in the molecular pathogenesis of osteogenesis imperfecta. Am J Med Genet (1993) 0.88
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score. Ann Oncol (2008) 0.88
Achilles and patellar tendinopathies in athletes: pathogenesis and surgical treatment. Bull Hosp Jt Dis (1996) 0.88
Fluorescence in situ hybridization analysis of CCND3 gene as marker of progression in bladder carcinoma. J Biol Regul Homeost Agents (2013) 0.87
Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists. Virchows Arch (2014) 0.87
Intraoperative frozen section diagnosis in urological oncology. Eur Urol (2005) 0.86
Primary primitive neuroectodermal tumour of the urinary bladder: a clinico-pathological study emphasising immunohistochemical, ultrastructural and molecular analyses. J Clin Pathol (2006) 0.86
Metabolic and hemodynamic changes during recovery and tracheal extubation in neurosurgical patients: immediate versus delayed recovery. Anesth Analg (1999) 0.86
Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine alpha 1(I) 901 substitution in a type-I collagen gene. Hum Genet (1992) 0.85
Standardized mitotic counts in breast cancer. Evaluation of the method. Pathol Res Pract (1996) 0.85
Immunohistochemical evaluation of global DNA methylation and histone acetylation in papillary urothelial neoplasm of low malignant potential. Int J Immunopathol Pharmacol (2008) 0.85
Prostatic invasive adenocarcinoma. Effect of combination endocrine therapy (LHRH agonist and flutamide) on the expression and location of proliferating cell nuclear antigen (PCNA). Pathol Res Pract (1993) 0.85
Pelvic and para-aortic lymph nodal positivity in the ovarian carcinoma: its prognostic significance. Eur J Gynaecol Oncol (1988) 0.85
Osteogenesis imperfecta: morphological, histochemical and biochemical aspects. Modifications induced by (+)-catechin. Connect Tissue Res (1977) 0.85
Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemase. Int J Immunopathol Pharmacol (2012) 0.85